CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 805 of 2
Non-Antibody Products
Page 805 of 2,608
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Docosahexaenoic Acid methyl ester | An esterified form of DHA; has been used as a reference standard in the qu… | 500 mg | 10006865-500 | More Info |
| Docosahexaenoic Acid Quant-PAK | The DHA Quant-PAK has been designed for the convenient, precise quantifica… | 1 ea | 10006829-1EA | More Info |
| Docosahexaenoyl Ethanolamide | The ethanolamine amide of DHA that has been detected in both brain and ret… | 10 mg | 10007534-10 | More Info |
| Docosahexaenoyl Ethanolamide | The ethanolamine amide of DHA that has been detected in both brain and ret… | 25 mg | 10007534-25 | More Info |
| Docosahexaenoyl Ethanolamide | The ethanolamine amide of DHA that has been detected in both brain and ret… | 5 mg | 10007534-5 | More Info |
| Docosahexaenoyl Ethanolamide | The ethanolamine amide of DHA that has been detected in both brain and ret… | 50 mg | 10007534-50 | More Info |
| Docosahexaenoyl Ethanolamide-d4 | An internal standard for the quantification of DHEA by GC- or LC-MS | 1 mg | 9001108-1 | More Info |
| Docosahexaenoyl Ethanolamide-d4 | An internal standard for the quantification of DHEA by GC- or LC-MS | 100 µg | 9001108-100 | More Info |
| Docosahexaenoyl Ethanolamide-d4 | An internal standard for the quantification of DHEA by GC- or LC-MS | 5 mg | 9001108-5 | More Info |
| Docosahexaenoyl Ethanolamide-d4 | An internal standard for the quantification of DHEA by GC- or LC-MS | 500 µg | 9001108-500 | More Info |
| Docosahexaenoyl Glycine | Consists of docosahexaenoic acid, an ω-3 PUFA, with glycine attached… | 10 mg | 9000328-10 | More Info |
| Docosahexaenoyl Glycine | Consists of docosahexaenoic acid, an ω-3 PUFA, with glycine attached… | 100 mg | 9000328-100 | More Info |
| Docosahexaenoyl Glycine | Consists of docosahexaenoic acid, an ω-3 PUFA, with glycine attached… | 5 mg | 9000328-5 | More Info |
| Docosahexaenoyl Glycine | Consists of docosahexaenoic acid, an ω-3 PUFA, with glycine attached… | 50 mg | 9000328-50 | More Info |
| 1-Docosahexaenoyl-2-hydroxy-sn-glycero-3-PC | A lysophospholipid; has been found in shark liver extract; decreases LPS-i… | 1 mg | 37340-1 | More Info |
| 1-Docosahexaenoyl-2-hydroxy-sn-glycero-3-PC | A lysophospholipid; has been found in shark liver extract; decreases LPS-i… | 10 mg | 37340-10 | More Info |
| 1-Docosahexaenoyl-2-hydroxy-sn-glycero-3-PC | A lysophospholipid; has been found in shark liver extract; decreases LPS-i… | 25 mg | 37340-25 | More Info |
| 1-Docosahexaenoyl-2-hydroxy-sn-glycero-3-PC | A lysophospholipid; has been found in shark liver extract; decreases LPS-i… | 5 mg | 37340-5 | More Info |
| Docosahexaenoyl-L-carnitine (chloride) | A long-chain acylcarnitine; decreased venous cord plasma levels are associ… | 10 mg | 38350-10 | More Info |
| Docosahexaenoyl-L-carnitine (chloride) | A long-chain acylcarnitine; decreased venous cord plasma levels are associ… | 25 mg | 38350-25 | More Info |
| Docosahexaenoyl-L-carnitine (chloride) | A long-chain acylcarnitine; decreased venous cord plasma levels are associ… | 5 mg | 38350-5 | More Info |
| Docosahexaenoyl-L-carnitine (chloride) | A long-chain acylcarnitine; decreased venous cord plasma levels are associ… | 50 mg | 38350-50 | More Info |
| 1-Docosahexaenoyl-rac-glycerol | A monoacylglycerol; reduces ET-1-induced smooth muscle tension in isolated… | 1 mg | 35871-1 | More Info |
| 1-Docosahexaenoyl-rac-glycerol | A monoacylglycerol; reduces ET-1-induced smooth muscle tension in isolated… | 10 mg | 35871-10 | More Info |
| 1-Docosahexaenoyl-rac-glycerol | A monoacylglycerol; reduces ET-1-induced smooth muscle tension in isolated… | 5 mg | 35871-5 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile